Arrowhead Pharmaceuticals, Inc. ( ARWR ) Q2 2026 Earnings Call May 7, 2026 4:30 PM EDT

Company Participants

Vincent Anzalone - Head of Investor Relations & VP

Dr. Christopher Anzalone - Chairman, CEO & President

Andy Davis - SVP of Cardiovascular & Head of Metabolic Franchise

James Hamilton - Chief Medical Officer and Head of R&D

Daniel Apel - Chief Financial Officer

Conference Call Participants

Edward Tenthoff - Piper Sandler & Co., Research Division

Jason Gerberry - BofA Securities, Research Division

Ron Feiner - JPMorgan Chase & Co, Research Division

Avraham Novick - Morgan Stanley, Research Division

Maurice Raycroft - Jefferies LLC, Research Division

Joseph Thome - TD Cowen, Research Division

Patrick Trucchio - H.C.…